ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.

Mahua Dey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.